Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT01858896

GLP-1 and Hypoglycemia

Conditions: Type 2 Diabetes Mellitus

Sex: All
Ages: 18 Years – 45 Years
Healthy volunteers: Yes
Phase: EARLY_PHASE1
Enrollment: 28
Sponsor: University of Maryland, Baltimore

Location: University of Maryland, Baltimore Baltimore Maryland

Summary

Low blood sugar can negatively affect how blood vessels function, and this can lead to an increase in the risk for heart attacks, strokes and other problems related to the stiffening and blockage of blood vessels. The purpose of this study is to learn if and how glucagon-like peptide-1 (GLP-1; a naturally occurring hormone in the gut) changes the effects that low blood sugar levels have on blood vessels.

Eligibility Criteria

Inclusion Criteria: * 14 (7 males, 7 females) healthy controls age 30-60 yr. * 14 (7 males, 7 females) people with type 2 DM age 30-60 yr. * For type 2 DM: HbA1c 6-10.0% * No significant diabetic tissue complications (i.e. history of retinopathy, neuropathy, stasis ulcers, etc.) * Body mass index \>25kg • m-2 Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01858896). StuddyBuddy aggregates publicly available trial information.